CMS has added two drugs/biologics (HCPCS C9292 Injection perttzumab, 10 mg and HCPCS C9293 Injection, glucarpidase, 10 units) to the ASC list of payable drugs/biologics effective Oct. 1, 2012.
The list of covered ancillary services for 2012 has been updated on ASCA’s website here.
Related Articles on Coding, Billing and Collections:
How to Successfully Handle Out-of-Network Contracts in ASCs
Maine Physician Pays $321K to Settle False Billing Claims
5 Tactics to Negotiate Bundled Payments for Surgery Centers
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
